So-Young’s Revenue Surge Fails to Calm Investor Concerns as Losses Widen
So-Young’s Revenue Surge Fails to Calm Investor Concerns as Losses Widen
So-Young International Inc., the Chinese medical aesthetics platform listed on Nasdaq under the ticker SY, reported strong revenue growth for the first quarter of 2026. However, the company’s widening losses and higher operating costs have raised fresh concerns among investors.
According to the company’s latest unaudited financial results, total revenue rose to RMB432.8 million, up 45.6% year over year from RMB297.3 million in the same period of 2025. The main driver was So-Young’s fast-growing aesthetic treatment services business, which generated RMB282.4 million, compared with RMB98.8 million a year earlier.
Revenue Growth Driven by Aesthetic Centers
So-Young’s branded aesthetic centers remained the company’s strongest growth engine. The business benefited from higher customer traffic, more treatment visits, and expansion across major Chinese cities.
The company said verified treatment visits at its branded centers reached about 148,000 during the quarter, compared with roughly 54,400 in the prior-year period. Verified aesthetic treatments also increased sharply to more than 325,800, up from about 123,400 a year earlier.
Active users reached more than 213,000 for the 12 months ended March 31, 2026, showing that demand for beauty and medical aesthetic services remains strong in China.
Losses Continue to Widen
Despite the strong sales growth, So-Young posted a larger net loss. Net loss attributable to the company reached RMB49.2 million, compared with a loss of RMB33.1 million in the first quarter of 2025.
On a non-GAAP basis, net loss widened to RMB46.6 million, compared with RMB31.5 million a year earlier. Basic and diluted loss per ADS also increased to RMB0.48, compared with RMB0.32 in the same period last year.
Higher Costs Pressure Profitability
The company’s cost of revenue rose 65.8% year over year to RMB251.0 million. This increase was mainly linked to the expansion of branded aesthetic centers, which require spending on staff, materials, rent, equipment, and daily operations.
Operating expenses also increased to RMB239.7 million, up 26.6% from the previous year. Sales and marketing expenses rose 33.7%, while general and administrative expenses increased 42.5%. These figures suggest So-Young is still spending heavily to grow its offline network and attract customers.
Online Platform Business Shows Weakness
While the offline aesthetic center business expanded quickly, So-Young’s information and reservation services declined. Revenue from this segment fell 34.0% year over year to RMB80.3 million.
This decline was mainly due to fewer medical service providers subscribing to the company’s online information services. The drop shows a key challenge for So-Young: its older online platform model is losing momentum while the newer offline center model is still costly to scale.
Clinic Network Expansion Remains Central
As of March 31, 2026, So-Young operated 54 branded aesthetic centers across 16 major Chinese cities. Of these, 53 were directly operated and one was franchised.
The company said 41 centers achieved center-level profitability during the quarter, while 48 centers generated positive quarterly operating cash flow. This indicates that many individual clinics are improving, even though the company as a whole remains unprofitable.
Management Remains Optimistic
So-Young’s management said the company will continue to focus on scale, efficiency, standardized medical delivery, supply chain advantages, and measured expansion. The company believes these efforts can create long-term value for users, partners, and shareholders.
For the second quarter of 2026, So-Young expects aesthetic treatment services revenue to reach between RMB307.0 million and RMB317.0 million. That would represent year-over-year growth of about 112.6% to 119.5%.
Investor Concern Remains
The key issue is not whether So-Young can grow revenue. The latest results clearly show strong top-line momentum. The bigger question is whether the company can convert growth into sustainable profit.
Investors may remain cautious because revenue growth is being accompanied by wider losses, rising marketing costs, and pressure in the online services segment. Until So-Young proves that its expanding clinic network can support company-wide profitability, the stock may continue to face uncertainty.
Conclusion
So-Young delivered impressive first-quarter revenue growth, led by rapid expansion in aesthetic treatment services. However, the stronger sales were overshadowed by widening losses and higher operating costs.
The company’s future will depend on whether it can balance expansion with financial discipline. If So-Young can improve margins, stabilize its online business, and keep clinic-level profitability moving higher, its long-term outlook could improve. For now, the latest results present a mixed picture: strong demand, fast growth, but continued pressure on earnings.
#SlimScan #GrowthStocks #CANSLIM